Best Pract Res Clin Gastroenterol. 2011 Aug;25(4-5):535-46.

Aminosalicylates.

Source

Christian Doppler Laboratory for Molecular Cancer Chemoprevention, Division of Gastroenterology and Hepatology, Department of Medicine 3, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, Austria.

Abstract

Aminosalicylates are the most common drugs for the primary treatment of inflammatory bowel disease. Various pro-drugs and formulations were developed in order to improve pharmacological profiles, optimize bioavailability and to gain highest efficacy in the treatment of ulcerative colitis (UC) and Crohn's disease. In vitro studies have greatly contributed to the understanding of the molecular actions in vivo and clinical studies have proven aminosalicylates to be effective and safe. This review summarizes the current knowledge on the molecular, pharmacological and clinical properties of aminosalicylates with respect to chemoprevention for UC-associated colorectal cancer.

PMID:: 22122769; [PubMed - in process]

Publication Types

Research Support, Non-U.S. Gov't

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

Review Controversies with aminosalicylates in inflammatory bowel disease. [Rev Gastroenterol Disord. 2004]
Review Controversies with aminosalicylates in inflammatory bowel disease.
Lim WC, Hanauer SB. Rev Gastroenterol Disord. 2004 Summer; 4(3):104-17.
Review [Medical therapy of inflammatory bowel diseases: ulcerative colitis]. [Orv Hetil. 2007]
Review [Medical therapy of inflammatory bowel diseases: ulcerative colitis].
Lakatos L, Lakatos PL. Orv Hetil. 2007 Jun 24; 148(25):1163-70.
Review The role of aminosalicylates at the beginning of the new millennium in the treatment of chronic inflammatory bowel disease. [Eur J Clin Pharmacol. 2000]
Review The role of aminosalicylates at the beginning of the new millennium in the treatment of chronic inflammatory bowel disease.
Klotz U. Eur J Clin Pharmacol. 2000 Aug; 56(5):353-62.
Review Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease. [Drug Saf. 1991]
Review Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
Hanauer SB, Stathopoulos G. Drug Saf. 1991 May-Jun; 6(3):192-219.
Colorectal adenocarcinoma in Crohn's disease: a retrospective histologic study. [Dis Colon Rectum. 1997]
Colorectal adenocarcinoma in Crohn's disease: a retrospective histologic study.
Rubio CA, Befrits R. Dis Colon Rectum. 1997 Sep; 40(9):1072-8.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Aminosalicylates.
Aminosalicylates.
Best Pract Res Clin Gastroenterol. 2011 Aug ;25(4-5):535-46.

PubMed
Top 10 plant viruses in molecular plant pathology.
Top 10 plant viruses in molecular plant pathology.
Mol Plant Pathol. 2011 Dec ;12(9):938-54. doi: 10.1111/j.1364-3703.2011.00752.x. Epub 2011 Oct 21 .

PubMed
Susceptibility of laughing gulls (Larus atricilla) to H5N1 and H5N3 highly patho...
Susceptibility of laughing gulls (Larus atricilla) to H5N1 and H5N3 highly pathogenic avian influenza viruses.
Avian Dis. 2002 Oct-Dec ;46(4):877-85.

PubMed
Prognosis of angina with and without a diagnosis: 11 year follow up in the White...
Prognosis of angina with and without a diagnosis: 11 year follow up in the Whitehall II prospective cohort study.
BMJ. 2003 Oct 18 ;327(7420):895.

PubMed
Job strain, job demands, decision latitude, and risk of coronary heart disease w...
Job strain, job demands, decision latitude, and risk of coronary heart disease within the Whitehall II study.
J Epidemiol Community Health. 2003 Feb ;57(2):147-53.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Aminosalicylates.

Source

Abstract

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information